Zeiss Pharma Limited, a active public limited company, was established on 13 March 2014 in Panchkula, Haryana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233HR2014PLC052139. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹14.05 Cr.
It upholds a compliant status. Employing 155 professional, Its leadership includes Satyapal Bansal (Director), Neeraj Bansal (Director), Sat Pal (Director). Past directors included Upasana, Vikas Gupta, Ashu Dhiman. It holds ₹190.23 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 4Th Floor, Plot No.16 Sector 22, It Park, Panchkula, Haryana, 134109.
U24233HR2014PLC052139
052139
13 March 2014
₹15.00 Cr
₹14.05 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Zeiss Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satyapal Bansal | Director | 25 Apr 2016 | Current |
| Neeraj Bansal | Director | 25 Apr 2016 | Current |
| Sat Pal | Director | 13 Mar 2014 | Current |
| Vikas Gupta | Whole-Time Director | 13 Mar 2014 | Current |
| Vinij Gupta | Cfo | 24 Apr 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Director | 24 Apr 2016 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Zeiss Pharma Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 16.49% increase. The company also saw a substantial improvement in profitability, with a 257.68% increase in profit. The company's net worth Soared by an impressive increase of 3059%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Zeiss Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,902,278,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Aug 2017 | Hdfc Bank Limited | ₹10.00 Cr | Open |
| 30 Nov 2015 | Hdfc Bank Limited | ₹180.23 Cr | Open |
Explore comprehensive loan charge details -
Zeiss Pharma has a workforce of 155 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Zeiss Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zeiss Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Vikas Gupta was appointed as a Ceo was appointed as a Ceo on 06 Dec 2024 & has been associated with this company since 1 year 19 days . was completed.
Zeiss Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Zeiss Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited of Rs. 180.23 Cr registered on 30 Nov 2015 with Charge ID 10614311 was modified on 13 Mar 2024. was completed.
Rupam was appointed as a Company Secretary was appointed as a Company Secretary on 23 Jan 2024 & has been associated with this company since 1 year 11 months . was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 10.00 Cr with Charge ID 100136360 was registered on 21 Aug 2017. was completed.
The CIN of Zeiss Pharma Limited is U24233HR2014PLC052139.
Zeiss Pharma Limited is headquartered at 4Th Floor, Plot No.16 Sector 22, It Park, Panchkula, Haryana, 134109.
Zeiss Pharma Limited was incorporated on 13 March 2014.
The current directors of Zeiss Pharma Limited are
The primary industry of Zeiss Pharma Limited is Manufacturing.
Zeiss Pharma Limited is unlisted.
The authorized capital of Zeiss Pharma Limited is ₹15.00 Cr, and the paid-up capital is ₹14.05 Cr.
The compliance status of Zeiss Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX